We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

1 hedge funds and large institutions have $19K invested in ENZON PHARMACEUTICALS INC in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more capital invested

Capital invested by funds: $12.5K → $19K (+$6.53K)

50% less funds holding

Funds holding: 2 → 1 (-1)

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$19K – – –

ENZN Hedge Fund Activity: Q2 2017 in Review

1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2017, worth a combined $19K — up 52% from $12.5K a quarter earlier.

Fund positioning in ENZN was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2017, down from 2 in Q1 2017.
  • Funds reported $19K of ENZON PHARMACEUTICALS INC stock for Q2 2017, up 52% quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2017 and 0 closed out.

Based on aggregated 13F filings for Q2 2017.